SERIES OF METABOLITES AS BIOMARKERS FOR THE DIAGNOSIS OF PANCREATIC CANCER
The present invention is comprised in the field of medicine, pharmacology, chemistry, biochemistry and biotechnology, and it relates to different series of metabolites present in serum capable of differentiating healthy patients from patients with pancreatic cancer (PC). The invention has an applica...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
24.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is comprised in the field of medicine, pharmacology, chemistry, biochemistry and biotechnology, and it relates to different series of metabolites present in serum capable of differentiating healthy patients from patients with pancreatic cancer (PC). The invention has an application in the clinical diagnosis of a pathology such as PC.
La présente invention s'inscrit dans le domaine de la médecine, de la pharmacologie, de la chimie, de la biochimie et de la biotechnologie, et elle concerne différentes séries de métabolites présentes dans le sérum pouvant différencier des patients sains de patients atteints d'un cancer du pancréas (PC). L'invention a une application dans le diagnostic clinique d'une pathologie telle que PC. |
---|---|
Bibliography: | Application Number: WO2020EP67255 |